SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026175
Filing Date
2021-11-10
Accepted
2021-11-10 16:35:49
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20210930_10q.htm   iXBRL 10-Q 729178
2 EXHIBIT 31.1 ex_303945.htm EX-31.1 13485
3 EXHIBIT 31.2 ex_303946.htm EX-31.2 13477
4 EXHIBIT 32.1 ex_303947.htm EX-32.1 5738
5 EXHIBIT 32.2 ex_303948.htm EX-32.2 5754
11 a.jpg GRAPHIC 30370
  Complete submission text file 0001437749-21-026175.txt   4000929

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20210930.xsd EX-101.SCH 43633
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20210930_cal.xml EX-101.CAL 33226
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20210930_def.xml EX-101.DEF 271377
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20210930_lab.xml EX-101.LAB 235829
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20210930_pre.xml EX-101.PRE 295247
12 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20210930_10q_htm.xml XML 542057
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 211397255
SIC: 2834 Pharmaceutical Preparations